Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets — Worldwide, 2019

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Fukunaga, Rena ; Glaziou, Philippe ; Harris, Jennifer B. ; Date, Anand ; Floyd, Katherine ; Kasaeva, Tereza
• Description:
  Although Tuberculosis (TB) is curable and preventable, in 2019, TB remained the leading cause of death from a single infectious agent Worldwide and the leading cause of death among persons living with HIV infection (1). The World Health Organization's (WHO's) End TB Strategy set ambitious targets for 2020, including a 20% reduction in TB incidence and a 35% reduction in the number of TB deaths compared with 2015, as well as zero TB-affected households facing catastrophic costs (defined as costs exceeding 20% of annual household income) (2). In addition, during the 2018 United Nations High-Level Meeting on TB (UNHLM-TB), all member states committed to setting 2018-2022 targets that included provision of TB treatment to 40 million persons and TB preventive treatment (TPT) to 30 million persons, including 6 million persons living with HIV infection and 24 million household contacts of patients with confirmed TB (4 million aged <5 years and 20 million aged ≥5 years) (3,4). Annual data reported to WHO by 215 countries and territories, supplemented by surveys assessing TB prevalence and patient costs in some countries, were used to estimate TB incidence, the number of persons accessing TB curative and preventive treatment, and the percentage of TB-affected households facing catastrophic costs (1). Globally, TB illness developed in an estimated 10 million persons in 2019, representing a decline in incidence of 2.3% from 2018 and 9% since 2015. An estimated 1.4 million TB-related deaths occurred, a decline of 7% from 2018 and 14% since 2015. Although progress has been made, the world is not on track to achieve the 2020 End TB Strategy incidence and Mortality targets (1). Efforts to expand access to TB curative and preventive treatment need to be substantially amplified for UNHLM-TB 2022 targets to be met.
• Subjects:
  CoronaVirus Infections COVID-19 Disease Eradication Global Health Goals Humans Incidence Tuberculosis
• Source:
  MMWR Morbidity Mortal Weekly Rep. 70(12):427-430
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  33764960
• Pubmed Central ID:
  PMC7993552
• Document Type:
  Journal Article
• Pages in Document:
  4 pdf pages
• Volume:
  70
• Issue:
  12
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:87d10cec090c38bc71d28672a45f4552ce4c4c3d879698383800c08920339363e5f1db6cf22cd77645552b29c0f17714fe74d620cb36b01f7dd63dee7b24238f
• Download URL:
  https://stacks.cdc.gov/view/cdc/104801/cdc_104801_DS1.pdf
• File Type:
  [PDF - 196.56 KB ]